As filed with the U.S. Securities and Exchange Commission on December 1, 2025. Registration No. 333-290927 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Envoy Medical, Inc. (Exact name of registrant as specified in its charter) Delaware 3842 86-1369123 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (IRS Employer Identification ...

Core Viewpoint - Catheter Precision, Inc. has acquired heart failure-related assets from Cardionomic, Inc., marking a significant milestone in expanding its product offerings in the cardiac electrophysiology market [1][2][3] Group 1: Acquisition Details - The acquisition involves certain assets related to a new therapy for acute decompensated heart failure (ADHF), a condition affecting over 1 million Americans annually [2] - The CPNS System, developed by Cardionomic, utilizes electrical stimulation via a temporary catheter in the pulmonary artery to target the root cause of heart failure [2] - Initial studies of the CPNS System have shown positive results, indicating potential for effective treatment options [2] Group 2: Company Overview - Catheter Precision is focused on developing innovative medical devices aimed at improving the treatment of cardiac arrhythmias [3] - The company collaborates with physicians to advance its products and bring new solutions to market [3]

As filed with the Securities and Exchange Commission on February 20, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MICROBOT MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 2836 94-3078125 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 288 Grove Street, ...